Drug intelligence / Profile preview

Antiviral Dripping Pills

Development stage: Unknown
Lead developer: Zhejiang Tianyitang Pharmaceutical
Administration: Oral

Overview

Antiviral Dripping Pills (Kangbingdu Diwan) is a traditional Chinese medicine (TCM) product developed and manufactured by Zhejiang Tianyitang Pharmaceutical. Formulated as dripping pills for oral administration, this medication is intended for the treatment of viral infections, including the common cold and influenza. In the context of TCM theory, the formulation is designed to clear heat, remove toxins, and cool the blood. The dripping pill dosage form is a modern TCM pharmaceutical preparation intended to improve the solubility and bioavailability of the active herbal components compared to traditional pill or tablet formats. It is a commercially approved product in China.

Brand names: Kangbingdu Diwan
Other names: 抗病毒滴丸Kangbingdu Dripping Pills

Beyond the preview

Go deeper on Antiviral Dripping Pills.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Antiviral Dripping Pills.

Explore the full profile